Adaptive Biotechnologies Corp (Adaptive) is a developer of immune-driven medicine. Its products include immunoSEQ and clonoSEQ. The company provides immune-sequencing platform to laboratories for conducting research in the areas of oncology and other immune-mediated diseases, and TCR screening for the development of vaccines. Adaptive develops assays for both clinical diagnosis and therapeutic monitoring for a variety of disorders and conditions. It specializes in combining high-throughput sequencing and expert bioinformatics to profile T-cell and B-cell receptors. The company translates immune-sequencing discoveries into clinical diagnostics and therapeutic development to improve patient care. It works in partnership with institutions and biopharmaceutical companies. The company has offices in South San Francisco, San Diego and New York. Adaptive is headquartered in Seattle, Washington, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Note: Some sections may be missing if data is unavailable for the company
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Adaptive Biotechnologies Corp
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
- Adaptive Biotechnologies Corp Company Overview
- Adaptive Biotechnologies Corp Company Snapshot
- Adaptive Biotechnologies Corp Pipeline Products and Ongoing Clinical Trials Overview
- Adaptive Biotechnologies Corp - Pipeline Analysis Overview
- Adaptive Biotechnologies Corp - Key Facts
- Adaptive Biotechnologies Corp - Major Products and Services
- Adaptive Biotechnologies Corp Pipeline Products by Development Stage
- Adaptive Biotechnologies Corp Pipeline Products Overview
- Anti-TNF Response Test - Crohn’s Disease
- Anti-TNF Response Test - Crohn’s Disease Product Overview
- ClonoSEQ Assay - ALL
- ClonoSEQ Assay - ALL Product Overview
- ClonoSEQ Assay - Non-Hodgkin’s Lymphoma
- ClonoSEQ Assay - Non-Hodgkin’s Lymphoma Product Overview
- Companion Diagnostic Test - Melanoma Cancer
- Companion Diagnostic Test - Melanoma Cancer Product Overview
- Diagnostic Assay - Cutaneous T-Cell Lymphoma
- Diagnostic Assay - Cutaneous T-Cell Lymphoma Product Overview
- Diagnostic Test - Infection
- Diagnostic Test - Infection Product Overview
- Immune System Profiling - Measure Of Vaccine Efficacy
- Immune System Profiling - Measure Of Vaccine Efficacy Product Overview
- immunoSEQ Assay - Post-Transplant
- immunoSEQ Assay - Post-Transplant Product Overview
- ImmunoSEQ Dx - Celiac Disease
- ImmunoSEQ Dx - Celiac Disease Product Overview
- ImmunoSEQ Dx - Lyme Disease
- ImmunoSEQ Dx - Lyme Disease Product Overview
- ImmunoSEQ Dx - Ovarian Cancer
- ImmunoSEQ Dx - Ovarian Cancer Product Overview
- Non-Invasive Diagnostic Test - Celiac Disease
- Non-Invasive Diagnostic Test - Celiac Disease Product Overview
- Pre - Symptomatic Biomarker - Type 1 Diabetes
- Pre - Symptomatic Biomarker - Type 1 Diabetes Product Overview
- Prediction Of Active Disease State - Crohn's Disease
- Prediction Of Active Disease State - Crohn's Disease Product Overview
- T-Detect - Celiac Disease
- T-Detect - Celiac Disease Product Overview
- T-Detect - Crohn’s Disease
- T-Detect - Crohn’s Disease Product Overview
- T-Detect - Lyme Disease
- T-Detect - Lyme Disease Product Overview
- T-Detect - Ovarian Cancer
- T-Detect - Ovarian Cancer Product Overview
- tilSEQ Assay
- tilSEQ Assay Product Overview
- Adaptive Biotechnologies Corp - Key Competitors
- Adaptive Biotechnologies Corp - Key Employees
- Adaptive Biotechnologies Corp - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
Recent Developments
Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- bluebird bio Inc
- Eureka Therapeutics Inc
- 10X Genomics Inc
- Illumina Inc
- Epic Sciences Inc
- Natera Inc
- MIODx
- Krystal Biotech Inc